Antigen presentation by Langerhans cells in vivo: Donor-derived Ia⁺ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens

Medicine & Life Sciences

• Isoantigens 100%
• Langerhans Cells 97%
• Delayed Hypersensitivity 92%
• Antigen Presentation 89%
• Cytotoxic T-Lymphocytes 88%
• Allografts 35%
• T-Lymphocytes 25%
• Allogeneic Cells 25%
• Antigen-Presenting Cells 24%
• Limbus Corneae 18%
• Transplants 14%
• Histocompatibility Antigens Class II 12%
• Cornea 10%
• Bone Marrow 8%
• Epithelial Cells 8%
• Haptens 7%
• Contact Dermatitis 6%
• Epidermal Cells 6%
• Skin 6%
• Lymphocyte Activation 6%
• Microspheres 5%
• Inbred C57BL Mouse 5%
• Antigens 3%